Judicious Use of Lipid Lowering Agents in the Management of NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western world. NAFLD encompasses a spectrum of histological features, including steatosis, steatohepatitis with balloon degeneration, and hepatic fibrosis leading to cirrhosis. In patients with advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Umair, Perumpail, Brandon J., John, Nimy, Sallam, Sandy, Shah, Neha D., Kwong, Waiyee, Cholankeril, George, Kim, Donghee, Ahmed, Aijaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313319/
https://www.ncbi.nlm.nih.gov/pubmed/30249980
http://dx.doi.org/10.3390/diseases6040087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313319/
https://www.ncbi.nlm.nih.gov/pubmed/30249980
http://dx.doi.org/10.3390/diseases6040087

Ejemplares similares